How to Support the Use of AI in Clinical Trials in France ?

Artificial intelligence (AI) could play a pivotal role in transforming clinical trials, a cornerstone for developing new treatments and medications. With the potential to improve recruitment, optimize complex data analysis, and reduce costs, AI represents a promising opportunity to accelerate these processes. France, with its rich ecosystem of health data, is well-positioned to harness this potential and promote the use of AI in implementing clinical trials. However, several challenges and obstacles need to be addressed.

Summary

  1. Introduction 
  2. Challenges and solution
  3. Conclusion 
  4. Use cases

Download
white paper

Get your questions answered by downloading the free pdf and learn more about our study!

  • Your information will be processed by Nova to send you the content requested. For more information about our processing or to exercise your GDPR rights, see our Privacy Policy
  • This field is for validation purposes and should be left unchanged.